Minimal Hepatic Encephalopathy Impairs Quality of Life

Journal of Clinical and Experimental Hepatology

Volumn 5, Issue S1, 2015, Pages S42-S48

  Agrawal, Swastik ^a   Umapathy, Sridharan ^a   Dhiman, Radha K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ammonia lowering therapy; Cirrhosis; Neurocognitive testing

Indexed keywords

AMMONIA; C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

DISEASE ASSOCIATION; DRIVING ABILITY; EMPLOYMENT; FALL RISK; FUNCTIONAL STATUS; HEPATIC ENCEPHALOPATHY; HIGH RISK POPULATION; HUMAN; JOB PERFORMANCE; LEARNING DISORDER; MEMORY DISORDER; MINIMAL HEPATIC ENCEPHALOPATHY; NAVIGATIONAL SKILL; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NOTTINGHAM HEALTH PROFILE; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SHORT FORM 36; SLEEP DISORDER; SOCIOECONOMIC BURDEN; SOCIOECONOMICS; SURVIVAL;

EID: 84924543115     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.11.006     Document Type: Review

References (87)

1. Seyan A.S., Hughes R.D., Shawcross D.L. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol 2010, 16:3347-3357.
2. Dhiman R.K., Saraswat V., Duseja A., Chawla Y.K. MHE. Consensus statement of a working party of the indian national association for study of the liver. JGastroenterol Hepatol 2010, 25:1029-1041.
3. Dhiman R.K., Chawla Y.K. Minimal hepatic encephalopathy. Indian J Gastroenterol 2009, 28:5-16.
4. Zeegen R., Drinkwater J.E., Dawson A.M. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 1970, 2:633-636.
5. Rikkers L., Jenko P., Rudman D., Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978, 75:462-469.
6. Kappus M.R., Bajaj J.S. Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol 2012, 10:1208-1219.
7. Hartmann I.J., Groeneweg M., Quero J.C., et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000, 95:2029-2034.
8. Stewart C.A., Malinchoc M., Kim W.R., Kamath P.S. Hepatic encephalopathy as a predictor of survival in patients with end stage liver disease. Liver Transpl 2007, 13:1366-1371.
9. Bajaj J.S., Wade J.B., Gibson D.P., et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 2011, 106:1646-1653.
10. Das A., Dhiman R.K., Saraswat V.A., Naik S.R. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. JGastroenterol Hepatol 2001, 16:531-535.
11. Prasad S., Dhiman R.K., Duseja A., Chawla Y., Sharma A., Agarwal R. Lactulose improves cognitive functions and health-related quality of life in cirrhotic patients with minimal hepatic encephalopathy. Hepatology 2007, 45:549-559.
12. Poordad F.F. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007, 25(suppl 1):3-9.
13. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn k, Blei A.T. Hepatic encephalopathy-definition, nomenclature diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
14. Boyer T.D., Haskal Z.J. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005, 41:386-400. American Association for the Study of Liver Diseases.
15. Quero J.C., Schalm S.W. Subclinical hepatic encephalopathy. Semin Liver Dis 1996, 16:321-328.
16. Groeneweg M., Moerland W., Quero J.C., Hop W.C.J., Krabbe P., Schalm S.W. Screening of subclinical hepatic encephalopathy. JHepatol 2000, 32:748-753.
17. Romero-Gomez M., Boza F., Garcia-Valdecasas M.S., García E., Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001, 96:2718-2723.
18. Dhiman R.K., Kurmi R., Thumburu K.K., et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010, 55:2381-2390.
19. Taneja S., Dhiman R.K., Khatri A., et al. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver. JClin Exp Hepatol 2012, 2:306-314.
20. 1H-magnetic resonance abnormalities after liver transplantation. JHepatol 2001, 35:598-604.
21. Lockwood A.H., Yap E.W., Wong W.H. Cerebral ammonia metabolism in patients with severe liver disease and minimal HE. JCereb Blood Flow Metab 1991, 11:337-341.
22. Kale R.A., Gupta R.K., Saraswat V.A., et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006, 43:698-706.
23. Butterworth R.F. Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology 2011, 53:1372-1376.
24. Ahboucha S., Butterworth R.F. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Int 2008, 52:575-587.
25. Dhiman R.K., Sawhney M.S., Chawla Y.K., Das G., Ram S., Dilawari J.B. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000, 45:1549-1552.
26. Yu-qiang N., Zheng Z., Yu-yuan L., Wei-hong S., Li P., Shou-jun D. Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy. Chin J Intern Med 2003, 42:261-266.
27. Sidhu S., Goyal O., Mishra B., Sood A., Chhina R.S., Soni R.K. Rifaximin improves psychometric performance and health related quality of life in patients with minimal hepatic encephalopathy (The RIME trial. Am J Gastroenterol 2011, 106:307-316.
28. Liu Q., Duon Z.P., Ha D.K., Bengmark S., Kurtovic J., Riordan S.M. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004, 39:1441-1449.
29. Bajaj J.S., Saeian K., Christensen K.M., et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008, 103:1707-1715.
30. Bajaj J.S., Schubert C.M., Heuman D.M., et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010, 138:2332-2340.
31. Riggio O., Ridola L., Pasquale C., et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011, 9:181-183.
32. Gupta A., Dhiman R.K., Kumari S., et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. JHepatol 2010, 53:849-855.
33. Shawcross D.L., Wright G., Olde Damink S.W., Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007, 22:125-138.
34. Shawcross D.L., Davies N.A., Williams R., Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. JHepatol 2004, 40:247-254.
35. de Vries H.E., Blom Roosemalen M.C., van Oosten M., et al. The influence of cytokines on the integrity of the blood-brain barrier invitro. JNeuroimmunol 1996, 64:37-43.
36. Duchini A., Govindarajan S., Santucci M., Zampi G., Hofman F.M. Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. JInvestig Med 1996, 44:474-482.
37. Didier N., Romero I.A., Créminon C., Wijkhuisen A., Grassi J., Mabondzo A. Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. JNeurochem 2003, 86:246-254.
38. Das K., Singh P., Chawla Y., Duseja A., Dhiman R.K., Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci 2008, 53:2793-2798.
39. Rama Rao K.V., Reddy P.V., Hazell A.S., Norenberg M.D. Manganese induces cell swelling in cultured astrocytes. Neurotoxicology 2007, 28:807-812.
40. Zhou Y.Q., Chen S.Y., Jiang L.D., et al. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. JGastroenterol Hepatol 2009, 24:408-415.
41. Navasa M., Forns X., Sanchez V., et al. Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. JHepatol 1996, 25:129-134.
42. Marchesini G., Bianchi G., Amodio P., et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001, 120:170-178.
43. Groeneweg M., Quero J.C., De Bruijn I., et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998, 28:45-49.
44. Gralnek I.M., Hays R.D., Kilbourne A., et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease-the LDQOL 1.0. Am J Gastroenterol 2000, 95:3552-3565.
45. Younossi Z.M., Guyatt G., Kiwi M., Boparai N., King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45:295-300.
46. Nie Y.Z., Zhang J.X., Li X.H. Evaluation the quality of life instrument in patients with chronic liver disease. Mod Rehabil 2001, 5:18-19.
47. Kim W.R., Lindor K.D., Malinchoc M., Petz J.L., Jorgensen R., Dickson E.R. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology 2000, 32:924-929.
48. Arguedas M.R., DeLawrence T.G., McGuire B.M. Influence of hepatic encephalopathy on health - related quality of life in patients with cirrhosis. Dig Dis Sci 2003, 48:1622-1626.
49. Mina A., Moran S., Ortiz-Olvera N., Mera R., Uribe M. Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis. Hepatol Res 2013 Aug 19, [Epub ahead of print].
50. Nardelli S., Pentassuglio I., Pasquale C., et al. Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients. Metab Brain Dis 2013 Jun, 28:239-243.
51. Bajaj J.S., Heuman D.M., Wade J.B., et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011 Feb, 140:478-487.
52. Cordoba J., Cabrera J., Lataif L., Penev P., Zee P., Blei A.T. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998, 27:339-345.
53. Bianchi G., Marchesini G., Nicolino F., et al. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis 2005, 37:593-600.
54. Montagnese S., Middleton B., Skene D.J., Morgan M.Y. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. Liver Int 2009, 29:1372-1382.
55. Mostacci B., Ferlisi M., Baldi A.A., et al. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci 2008, 29:237-240.
56. Samanta J., Dhiman R.K., Khatri A., et al. Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. Metab Brain Dis 2013, 28:249-259.
57. Montagnese S., De Pittà C., De Rui M., et al. Sleep-wake abnormalities in patients with cirrhosis. Hepatology 2013 Jun 6, [Epub ahead of print].
58. De Rui M., Schiff S., Aprile D., et al. Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking. Metab Brain Dis 2013, 28:245-248.
59. Ortiz M., Córdoba J., Jacas C., Flavià M., Esteban R., Guardia J. Neuropsychological abnormalities in cirrhosis include learning impairment. JHepatol 2006, 44:104-110.
60. Weissenborn K., Heidenreich S., Giewekemeyer K., Rückert N., Hecker H. Memory function in early hepatic encephalopathy. JHepatol 2003, 39:320-325.
61. Weissenborn K., Burchert W., Bokemeyer M., et al. Regional differences of cerebral glucose metabolism in patients with liver cirrhosis depending on the grade of portosystemic encephalopathy (PSE). Advances in Hepatic Encephalopathy and Metabolism in Liver Disease 1997, 359-363. Medical Faculty of the University of Newcastle-upon-Tyne, Newcastle upon Tyne. C. Record, H. Al Mardini (Eds.).
62. Lockwood A.H., Weissenborn K., Bokemeyer M., Tietge U., Burchert W. Correlations between cerebral glucose metabolism and neuropsychological test performance in non-alcoholic cirrhotics. Metab Brain Dis 2002, 17:29-40.
63. Erceg S., Monfort P., Hernandez-Viadel M., Rodrigo R., Montoliu C., Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 2005, 41:299-306.
64. Schomerus H., Hamster W., Blunck H., Reinhard U., Mayer K., Dolle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981, 26:622-630.
65. Watanabe A., Tuchida T., Yata Y., Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995, 10:239-248.
66. Srivastava A., Mehta R., Rothke S.P., Rademaker A.W., Blei A.T. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. JHepatol 1994, 21:1023-1028.
67. Wein C., Koch H., Popp B., Oehler G., Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004, 39:739-745.
68. Marotolli R.A., Cooney L.M., Wagner S., Doucette J., Tinetti M.E. Predictors of automobile crashes and moving violations among elderly drivers. Ann Intern Med 1994, 121:842-846.
69. Nyberg S.L., Baskin-Bey E.S., Mitchell M.M., et al. Early experience with HEADS: hepatic encephalopathy assessment driving simulator. Adv Transp Stud 2006, 53-62.
70. Bajaj J.S., Hafeezullah M., Hoffmann R.G., Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007, 102:1903-1909.
71. Bajaj J.S., Saeian K., Schubert C.M., et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009, 50:1175-1183.
72. Bajaj J.S., Hafeezullah M., Zadvornova Y., et al. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol 2009, 104:898-905.
73. Bajaj J.S., Hafeezullah M., Hoffmann R.G., et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008, 47:596-604.
74. Bajaj J.S., Saeian K., Hafeezullah M., Hoffmann R.G., Hammeke T.A. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin Gastroenterol Hepatol 2008, 6:1135-1139.
75. Bajaj J.S., Thacker L.R., Heuman D.M., et al. Driving simulation can improve insight into impaired driving skills in cirrhosis. Dig Dis Sci 2012, 57:554-560.
76. Román E., Córdoba J., Torrens M., et al. Minimal hepatic encephalopathy is associated with falls. Am J Gastroenterol 2011, 106:476-482.
77. Soriano G., Roman E., Cordoba J., et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2011, 55:1922-1930.
78. Collier J. Bone disorders in chronic liver disease. Hepatology 2007, 46:1271-1278.
79. Cohen S.M., Te H.S., Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. JArthroplasty 2005, 20:460-466.
80. Diamond T., Stiel D., Lunzer M., Wilkinson M., Roche J., Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990, 31:82-87.
81. Ström O., Borgstrom F., Zethraeus N., et al. Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. Acta Orthop 2008, 79:269-280.
82. Schomerus H., Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001, 16:37-41.
83. Stewart C.A., Smith G.E. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 2007, 4:677-685.
84. Romero-Gómez M., Córdoba J., Jover R., et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007, 45:879-885.
85. Yen C.L., Liaw Y.F. Somatosensory evoked potentials and number connection test in the detection of hepatic encephalopathy. Hepatogastroenterology 1990, 37:332-334.
86. Amodio P., Del Piccolo F., Marchetti P., et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999, 29:1662-1667.
87. Patidar K.R., Thacker L.R., Wade J.B., et al. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol 2014 Sep 2, 10.1038/ajg.2014.264.